Journal rankings · indicator year 2000
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2000
Biochemistry, Genetics and Molecular Biology journal rankings 2000
609 ranked journals · Field in Life Sciences
Biochemistry, Genetics and Molecular Biology has 609 ranked journals in 2000. The median journal has an OJR of 0.63, below the world average of 1.00; Q1 starts at OJR 1.08. The top three are Cell, Annual Review of Plant Physiology and Plant Molecular Biology, and Nature Genetics.
Ranks and citation indicators: 2000. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 1997–1999, the window the 2000 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Biochemistry, Genetics and Molecular Biology (14)
Up to Life Sciences609 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 1999. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 1997–1999, the window the 2000 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 1997–1999 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2000. | Compare |
|---|---|---|---|---|---|---|---|
1CellCell Press · United States | 11.63Q1 | 30.80no 1999 value | 1,300 | 97% | $11,400 | — | |
2Annual Review of Plant Physiology and Plant Molecular BiologyAnnual Reviews · United States | 10.68Q1 | 15.82no 1999 value | 82 | 5% | — | — | |
3Nature GeneticsNature Portfolio · United States | 8.26Q1 | 19.72no 1999 value | 1,047 | 11% | $12,690 | — | |
4NatureNature Portfolio · United Kingdom | 7.30Q1 | 9.25no 1999 value | 8,240 | 8% | $12,690 | — | |
5Pharmacological ReviewsAmerican Society for Pharmacology and Experimental Therapeutics · United States | 7.00Q1 | 14.21no 1999 value | 72 | 9% | $4,500 | — | |
6Molecular CellElsevier BV · United States | 6.61Q1 | 18.76no 1999 value | 395 | 90% | $10,400 | — | |
7Annual Review of Biophysics and Biomolecular StructureAnnual Reviews · United States | 5.51Q1 | 16.63no 1999 value | 55 | 14% | — | — | |
8ScienceAmerican Association for the Advancement of Science · United States | 4.96Q1 | 6.40no 1999 value | 12,290 | 2% | — | — | |
9The EMBO JournalOASpringer Nature · Germany | 4.91Q1 | 14.38no 1999 value | 2,100 | 94% | $7,990 | — | |
10Nature Cell BiologyNature Portfolio · United Kingdom | 4.90Q1 | 12.69no 1999 value | 179 | 10% | $12,690 | — | |
11Journal of Clinical InvestigationOAAmerican Society for Clinical Investigation · United States | 4.85Q1 | 12.12no 1999 value | 1,792 | 100% | $5,200 | — | |
12Biochimica et Biophysica Acta (BBA) - Reviews on BiomembranesElsevier BV · Netherlands | 4.58Q1 | 12.32no 1999 value | 41 | 9% | — | — | |
13The Journal of Cell BiologyRockefeller University Press · United States | 4.34Q1 | 13.49no 1999 value | 1,610 | 92% | — | — | |
14Proceedings of the National Academy of SciencesNational Academy of Sciences · United States | 4.17Q1 | 10.57no 1999 value | 8,261 | 93% | — | — | |
15Human Molecular GeneticsOxford University Press · United Kingdom | 3.72Q1 | 9.75no 1999 value | 852 | 21% | $4,390 | — | |
16Progress in Lipid ResearchElsevier BV · United Kingdom | 3.27Q1 | 5.48no 1999 value | 40 | 0% | $5,530 | — | |
17Annual Review of BiochemistryAnnual Reviews · United States | 3.22Q1 | 47.07no 1999 value | 85 | 6% | — | — | |
18Circulation ResearchLippincott Williams & Wilkins · United States | 3.13Q1 | 8.02no 1999 value | 961 | 56% | — | — | |
19Molecular and Cellular BiologyTaylor & Francis · United States | 3.10Q1 | 9.77no 1999 value | 2,361 | 87% | — | — | |
20Systematic BiologyOxford University Press · United States | 3.07Q1 | 5.24no 1999 value | 219 | 26% | $2,166 | — | |
21The American Journal of Human GeneticsElsevier BV · United States | 3.03Q1 | 7.84no 1999 value | 1,303 | 85% | $5,150 | — | |
22Physiological ReviewsAmerican Physiological Society · United States | 2.96Q1 | 25.60no 1999 value | 98 | 8% | — | — | |
23DevelopmentThe Company of Biologists · United Kingdom | 2.87Q1 | 9.72no 1999 value | 1,464 | 5% | — | — | |
24Pharmacology & TherapeuticsElsevier BV · United States | 2.84Q1 | 6.24no 1999 value | 184 | 1% | $5,660 | — | |
25Microbiology and Molecular Biology ReviewsAmerican Society for Microbiology · United States | 2.76Q1 | 21.30no 1999 value | 141 | 100% | — | — | |
26Nature Structural & Molecular BiologyNature Portfolio · United States | 2.71Q1 | 4.95no 1999 value | 81 | 0% | $12,690 | — | |
27American Journal Of PathologyElsevier BV · United States | 2.69Q1 | 6.32no 1999 value | 661 | 99% | $2,800 | — | |
28Biochimica et Biophysica Acta (BBA) - Reviews on CancerElsevier BV · Netherlands | 2.56Q1 | 4.65no 1999 value | 102 | 8% | $5,070 | — | |
29Molecular MicrobiologyWiley · United Kingdom | 2.55Q1 | 6.25no 1999 value | 1,418 | 57% | $4,430 | — | |
30StructureElsevier BV · United Kingdom | 2.49Q1 | 5.63no 1999 value | 516 | 100% | $9,350 | — | |
31Molecular Biology of the CellAmerican Society for Cell Biology · United States | 2.47Q1 | 7.78no 1999 value | 800 | 90% | — | — | |
32Journal of Biological ChemistryOAElsevier BV · United States | 2.46Q1 | 7.58no 1999 value | 15,065 | 98% | $3,430 | — | |
33Drug Metabolism ReviewsTaylor & Francis · United States | 2.42Q1 | 3.57no 1999 value | 111 | 0% | — | — | |
34TrAC Trends in Analytical ChemistryElsevier BV · Netherlands | 2.39Q1 | 3.12no 1999 value | 306 | 1% | $5,150 | — | |
35Annual Review of Cell and Developmental BiologyAnnual Reviews · United States | 2.37Q1 | 27.12no 1999 value | 65 | 8% | — | — | |
36Analytical ChemistryAmerican Chemical Society · United States | 2.30Q1 | 2.98no 1999 value | 3,933 | 7% | $4,500 | — | |
37Journal of Molecular Graphics and ModellingElsevier BV · United States | 2.28Q1 | 1.27no 1999 value | 110 | 1% | $3,940 | — | |
38Molecular NeurobiologySpringer Science+Business Media · United States | 2.27Q1 | 4.56no 1999 value | 78 | 0% | $4,590 | — | |
39Progress in Biophysics and Molecular BiologyElsevier BV · United Kingdom | 2.27Q1 | 5.17no 1999 value | 73 | 100% | $4,260 | — | |
40Human Gene TherapyMary Ann Liebert, Inc. · United States | 2.24Q1 | 5.57no 1999 value | 749 | 4% | — | — | |
41Molecular Biology and EvolutionOAOxford University Press · United States | 2.19Q1 | 5.22no 1999 value | 526 | 63% | $3,418 | — | |
42Nature BiotechnologyNature Portfolio · United States | 2.18Q1 | 3.87no 1999 value | 1,398 | 16% | $12,690 | — | |
43Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of LipidsElsevier BV · Netherlands | 2.17Q1 | 4.71no 1999 value | 215 | 6% | $3,670 | — | |
44Applied and Environmental MicrobiologyOAAmerican Society for Microbiology · United States | 2.16Q1 | 3.59no 1999 value | 2,640 | 95% | — | — | |
45OncogeneSpringer Nature · United Kingdom | 2.10Q1 | 6.27no 1999 value | 1,813 | 5% | $5,990 | — | |
46The Journal of Physical Chemistry BAmerican Chemical Society · United States | 2.04Q1 | 2.94no 1999 value | 4,734 | 5% | — | — | |
47Cell Death and DifferentiationSpringer Nature · United Kingdom | 2.03Q1 | 6.95no 1999 value | 378 | 12% | $5,790 | — | |
48Mutation Research/Reviews in Mutation ResearchElsevier BV · Netherlands | 2.02Q1 | 4.58no 1999 value | 92 | 6% | $4,160 | — | |
49The Annual Review of Pharmacology and ToxicologyAnnual Reviews · United States | 2.01Q1 | 20.32no 1999 value | 58 | 3% | — | — | |
50Critical Reviews in Eukaryotic Gene ExpressionBegell House · United States | 1.99Q1 | 4.98no 1999 value | 64 | 10% | — | — |
Subfields of Biochemistry, Genetics and Molecular Biology, compared.
- Molecular Biology519
- Genetics53
- Cancer Research12
- Cell Biology9
- Biophysics6
- Molecular Medicine4
- Biochemistry2
- Clinical Biochemistry2
- Developmental Biology1
- Structural Biology1
- Aging0
- Biotechnology0
- Endocrinology0
- Physiology0
Journals
Citations made in 2000. Corpus-wide, 66.2% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
209 additional Biochemistry, Genetics and Molecular Biology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 1997–1999, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2000. Publication window: 1997–1999. How these summaries are calculated
- Ranked journals
- 609
- Window papers (baseline)
- 310,927 Change unavailable from indicator year 1997
- Median OJR
- 0.628 Change unavailable from indicator year 1997
- Rising journals (2025)
- 141Comparison-group list (141)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 1997–1999 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 609 | 650 | 696 | 742 | 765 | 806 | 835 | 888 | 919 | 951 | 1,003 | 1,064 | 1,125 | 1,172 | 1,217 | 1,271 | 1,311 | 1,339 | 1,365 | 1,369 | 1,349 | 1,339 | 1,358 | 1,366 | 1,355 | 1,367 | |
| Window papers (baseline) | 310,927 | 335,262 | 354,210 | 375,343 | 388,415 | 415,247 | 441,606 | 472,036 | 497,712 | 532,780 | 565,943 | 595,190 | 615,359 | 631,115 | 652,778 | 672,042 | 683,714 | 684,441 | 678,826 | 679,352 | 690,127 | 717,801 | 750,552 | 768,440 | 764,327 | 768,613 | |
| Median OJR | 0.628 | 0.634 | 0.68 | 0.76 | 0.81 | 0.8465 | 0.872 | 0.894 | 0.921 | 0.95 | 0.98 | 1.03 | 1.02 | 0.990 | 0.986 | 0.97 | 0.96 | 0.93 | 0.925 | 0.915 | 0.912 | 0.90 | 0.890 | 0.8474 | 0.853 | 0.871 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 1.9% | 1,206 journals |
| Retracted papers per 1,000 | Pooled rate: 4.798 per 1,000 | 1,059 journals |
| Output growth | Median: -6.4% | 1,233 journals |
| Open access share | Median: 100.0% | 1,367 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,300 | 943 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 24.4% | 1,335 journals |
| Review share | Median: 0.3% | 1,367 journals |
| Articles-only OJR | Median: 0.87 | 1,336 journals |
| Uncited share | Median: 22.7% | 1,367 journals |
| Citation concentration | Median: 42.1% | 1,363 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.